🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Status
Completed
Location
Hospital Universitario Son Espases
Start Date
2016-04-07
Trial ID
NCT02692248
Treatments Being Tested
This is an open label, multicenter, dose escalation, phase Ib study to dete...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-10
Trial ID
NCT02741388
Treatments Being Tested
This is a prospective, single-arm, multicenter, phase II clinical trial to ...
Status
Not Yet Recruiting
Location
Daping Hospital, Third Military Medical University (Army Medical University)
Start Date
2025-02-01
Trial ID
NCT06778902
Treatments Being Tested
The purpose of this trial is to compare the efficacy and safety of Inotuzum...
Status
Completed
Location
Stoke Mandeville Hospital (including Wycombe Hospital)
Start Date
2013-10
Trial ID
NCT01679119
Treatments Being Tested
The purpose of this study is to determine the recommended dose of CMC544 ad...
Status
Completed
Location
AZ Sint Jan
Start Date
2012-12
Trial ID
NCT01562990
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
This is a multicenter, randomized, controlled, open-label Phase III clinica...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-06
Trial ID
NCT06792253
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-08
Trial ID
NCT01421173
The purpose of this study is to investigate efficacy and safety of Lenalido...
Status
Unknown
Location
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital)
Start Date
2020-06-14
Trial ID
NCT04432402
Treatments Being Tested